Upon completion of the activity, participants should be able to:
This educational initiative is intended for members of the Primary Care Team.
The American College of Endocrinology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Endocrinology designates this enduring activity for a maximum of 5.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.75 MOC Medical Knowledge point(s) in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC point(s) equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.
In accordance with the ACCME Standards for Commercial Support, The American Association of Clinical Endocrinology (AACE) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. AACE resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs. Furthermore, AACE seeks to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. AACE is committed to providing learners with high-quality CME.
The planners, reviewers, editors, staff, CME committee, and other members at the American Association of Clinical Endocrinology who control content have no relevant financial relationships to disclose.
First
MI
Last
Credentials
Position
Institution
Role
Disclosure(s)
Scott
Kahan
MD, MPH, FTOS
MALE
NCWW/JHU
Speaker
Nothing to disclose
Martin
M
Grajower
MD, FACP, FACE
Clinical Professor of Medicine
Albert Einstein College of Medicine
Abbott/AbbVie (Self: 1 financial relationship declared - Honorarium) Bayer (Self: 1 financial relationship declared - Honorarium) echosense (Self: 1 financial relationship declared - Honorarium) Novo Nordisk (Self: 1 financial relationship declared - Honorarium)
Amy
Fischl
MS RDN LDN BC-ADM CDCES
University of Chicago
Abbott Diabetes Care (Self: 1 financial relationship declared - Honorarium) Xeris Pharmaceuticals (Self: 1 financial relationship declared - Honorarium)
Monika
Agarwal
MD, MEHP, FACE
Associate Professor
University of Alabama at Birmingham
Reshmi
Srinath
MD
Assistant Professor/Director Weight and Metabolism Management Program
Icahn School of Medicine at Mount Sinai
Barham
Abu Dayyeh
MD MPH
Director of Advanced Endoscopy and Vice Chair of Innovation
Mayo Clinic, Rochester, MN
Apollo Endo-surgery (Self: 1 financial relationship declared - Grant/Research Support) Boston Scientific (Self: 1 financial relationship declared - Grant/Research Support) Endogenex (Self: 1 financial relationship declared - Ownership Interest includes stock, stock options, patent or other intellectual property) Spatz Medical (Self: 1 financial relationship declared - Grant/Research Support) USGI Medical (Self: 1 financial relationship declared - Grant/Research Support)
Taraneh
Solymani
Penn State College of Medicine
Teresa
LaMasters
Medical Director Bariatric Surgery
UnityPoint Clinic Weight Loss Specialists
ASMBS (Self: 1 financial relationship declared - Reimbursement for travel and registration as a speaker and board member) Ethicon (Self: 2 financial relationships declared - Honorarium, Consulting Fees (e.g., advisory boards)) INTUITIVE SURGICAL (Self: 2 financial relationships declared - Honorarium, Consulting Fees (e.g., advisory boards)) WL Gore (Self: 2 financial relationships declared - Honorarium, Consulting Fees (e.g., advisory boards))
Holly
F
Lofton
MD, DiplABOM
Clinical Associate Professor of Surgery and Medicine
NYU Grossman School of Medicine
Eli Lilly (Self: 1 financial relationship declared - Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received) Novo Nordisk (Self: 3 financial relationships declared - Honorarium, Consulting Fees (e.g., advisory boards), Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received)
Zhaoping
Li
MD, PhD
UCLA
AACE requires CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. AACE does not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.
The American Association of Clinical presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The American Association of Clinical Endocrinology assumes no liability for the information herein.